Skip to content

Leishmanolysin-like peptidase (LMLN)

Homo sapiens — UniProt Q96KR4

Gene: LMLNHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Leishmanolysin-like peptidase (LMLN) is a protein from Homo sapiens identified by UniProt accession Q96KR4, 647 residues long. MolForge cross-references it against 0 known binders and 30 disease associations.

  • UniProt accession: Q96KR4; gene symbol LMLN.
  • Organism: Homo sapiens.
  • Length: 647 amino acids.
  • Top disease associations (Open Targets): prostate carcinoma, prostate cancer and Familial prostate cancer.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameLeishmanolysin-like peptidase
UniProt accessionQ96KR4
GeneLMLN
OrganismHomo sapiens
Length647 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (30)

Diseases linked to this target (Open Targets).

  • prostate carcinoma · score 0.11
  • prostate cancer · score 0.11
  • Familial prostate cancer · score 0.11
  • infect · score 0.10
  • infection · score 0.10
  • Miyoshi myopathy · score 0.05
  • basophil count · score 0.05
  • visceral Leishmaniasis · score 0.03
  • neoplasm · score 0.02
  • cutaneous Leishmaniasis · score 0.01

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q96KR4-F1alphafoldPREDICTED81.18—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q96KR4.

Amino-acid sequence (647 residues)

MAAEWGGGVG YSGSGPGRSR WRWSGSVWVR SVLLLLGGLR ASATSTPVSL GSSPPCRHHV PSDTEVINKV HLKANHVVKR DVDEHLRIKT VYDKSVEELL PEKKNLVKNK LFPQAISYLE KTFQVRRPAG TILLSRQCAT NQYLRKENDP HRYCTGECAA HTKCGPVIVP EEHLQQCRVY RGGKWPHGAV GVPDQEGISD ADFVLYVGAL ATERCSHENI ISYAAYCQQE ANMDRPIAGY ANLCPNMIST QPQEFVGMLS TVKHEVIHAL GFSAGLFAFY HDKDGNPLTS RFADGLPPFN YSLGLYQWSD KVVRKVERLW DVRDNKIVRH TVYLLVTPRV VEEARKHFDC PVLEGMELEN QGGVGTELNH WEKRLLENEA MTGSHTQNRV LSRITLALME DTGRQMLSPY CDTLRSNPLQ LTCRQDQRAV AVCNLQKFPK PLPQEYQYFD ELSGIPAEDL PYYGGSVEIA DYCPFSQEFS WHLSGEYQRS SDCRILENQP EIFKNYGAEK YGPHSVCLIQ KSAFVMEKCE RKLSYPDWGS GCYQVSCSPQ GLKVWVQDTS YLCSRAGQVL PVSIQMNGWI HDGNLLCPSC WDFCELCPPE TDPPATNLTR ALPLDLCSCS SSLVVTLWLL LGNLFPLLAG FLLCIWH

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LMLN?

The strongest Open Targets associations for LMLN are prostate carcinoma, prostate cancer, Familial prostate cancer, infect and infection.

How long is the LMLN protein?

The Homo sapiens LMLN protein (UniProt Q96KR4) is 647 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Leishmanolysin-like peptidase with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ96KR4
GeneLMLN
OrganismHomo sapiens
Length647
Binders0
Diseases30
View on UniProt